Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

被引:0
|
作者
Barbagallo, Francesco Di Giacomo [1 ,3 ]
Bosco, Giosiana [1 ,3 ]
Di Marco, Maurizio [1 ]
Scilletta, Sabrina [1 ]
Miano, Nicoletta [1 ]
Musmeci, Marco [1 ]
Martedi, Marina [1 ]
Gonzalez-Lleo, Ana M. [2 ]
Ibarretxe, Daiana [2 ]
De Francesco, Ernestina Marianna [3 ]
Malaguarnera, Roberta [3 ]
Di Pino, Antonino [1 ]
Masana, Luis [2 ]
Purrello, Francesco [1 ]
Piro, Salvatore [1 ]
Scicali, Roberto [1 ]
机构
[1] Univ Catania, Garibaldi Hosp, Dept Clin & Expt Med, Internal Med, Via Palermo 636, I-95122 Catania, Italy
[2] Univ Rovira i Virgili, Hosp Univ St Joan, Unitat Med Vasc & Metab, Unitat Recerca Lipids & Arterioslcerosi, Reus, Spain
[3] Kore Univ Enna, Dept Med & Surg, Enna, Italy
关键词
Familial hypercholesterolemia; Low-density lipoprotein receptor; Glycemic status; Subclinical atherosclerosis; Cardiovascular risk; LOW-DENSITY-LIPOPROTEIN; RISK; BURDEN; SCORE; ASSOCIATION; VARIANTS; DISEASE; PROFILE;
D O I
10.1186/s12933-025-02683-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Familial hypercholesterolemia (FH) is a genetic condition characterized by elevated LDL-C and increased cardiovascular risk. Beyond LDL-C levels, the impact of genotype on glucose homeostasis has not been well evaluated. We aimed to evaluate the impact of genotype on glycemic status and on atherosclerotic injury in FH subjects. Methods We conducted a cross-sectional study on 322 FH subjects not on lipid-lowering therapy and without history of cardiovascular disease. Biochemical and genetic analyses as well as vascular profile assessment were obtained from all subjects. The study population was divided into two groups according to genotype: LDL receptor (LDLR) group and non-LDLR (NLDLR) group. Results The LDLR group exhibited a higher prevalence of low glycemic status (LGS) than the NLDLR group (44.1% vs. 26%, p < 0.01), whereas a high glycemic status (HGS) was more prevalent in the NLDLR group compared with LDLR group (74% vs. 55.9%, p < 0.01). The NLDLR group exhibited a higher prevalence of peripheral atherosclerotic plaques than the LDLR group (93.4% vs. 73%, p < 0.05), while coronary artery calcification (CAC) presence was more prevalent in the LDLR group compared with the NLDLR group (74.7% vs. 48%, p < 0.01). In a secondary analysis the study population was stratified into three groups based on LDLR genotype: NLDLR, LDLR defective, LDLR null groups. The prevalence of LGS progressively increased from the NLDLR to the LDLR null group, while HGS showed an inverse trend (p for trend < 0.05). Peripheral atherosclerotic plaque prevalence decreased from the NLDLR to the LDLR null group (p for trend < 0.05), while CAC prevalence increased progressively in the three groups (p for trend < 0.01). Logistic regression analysis showed that FH groups with an LDLR mutation were inversely associated with HGS (p for both < 0.01) and the LDLR null group exhibited the strongest association. Conclusions FH subjects with NLDLR mutations exhibited a worse glycemic profile, while null LDLR mutations showed the strongest inverse association with HGS. The integrations of genetic, lipid and glucose data could be useful to better identify the metabolic profile and the atherosclerosis distribution in FH subjects.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis
    Bosco, Giosiana
    Barbagallo, Francesco Di Giacomo
    Di Marco, Maurizio
    Scilletta, Sabrina
    Miano, Nicoletta
    Capuccio, Stefania
    Musmeci, Marco
    Di Mauro, Stefania
    Filippello, Agnese
    Scamporrino, Alessandra
    Di Pino, Antonino
    Masana, Luis
    Purrello, Francesco
    Piro, Salvatore
    Scicali, Roberto
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2025, 132 : 118 - 126
  • [2] A novel mutation of the LDL receptor gene leading to familial hypercholesterolemia
    Su, Pengyu
    Wang, Luya
    Lin, Jie
    Liu, Shu
    Xia, Junhui
    Xu, Yingjie
    Yong, Qiang
    Yang, Ya
    Pan, Xiaodong
    Du, Lanping
    Oin, Yanwen
    Wu, Zhaosu
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2009, 111 (07) : 646 - 651
  • [3] Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia
    Neefjes, Lisan A.
    ten Kate, Gert-Jan R.
    Rossi, Alexia
    Nieman, Koen
    Galema-Boers, Annette J.
    Langendonk, Janneke G.
    Weustink, Annick C.
    Mollet, Nico R.
    Sijbrands, Eric J.
    Krestin, Gabriel P.
    de Feyter, Pim J.
    ATHEROSCLEROSIS, 2011, 219 (02) : 721 - 727
  • [4] FAMILIAL HYPERCHOLESTEROLEMIA CAUSED BY A NONSENSE MUTATION IN CODON-329 OF THE LDL RECEPTOR GENE
    SOLBERG, K
    RODNINGEN, OK
    TONSTAD, S
    OSE, L
    LEREN, TP
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1994, 54 (08) : 605 - 609
  • [5] A combined LDL receptor/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia
    Soufi, Muhidien
    Rust, Stephan
    Walter, Michael
    Schaefer, Juergen R.
    GENE, 2013, 521 (01) : 200 - 203
  • [6] Screening for Subclinical Atherosclerosis in Patients with Familial Hypercholesterolemia: Insights and Implications
    Deniz, Muhammed Furkan
    Guven, Baris
    Ebeoglu, Abdullah Omer
    Gul, Omer Burak
    Nayir, Ali
    Ozkan, Pelinsu
    Bulat, Zubeyir
    Turk, Ibrahim
    Demirelce, Ozlem
    Kimyonok, Husamettin Alper
    Deniz, Habibe
    Ersanli, Murat Kazim
    Oktay, Veysel
    Konukoglu, Dildar
    Sinan, Umit Yasar
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [7] Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
    Jarauta, Estibaliz
    Bea-Sanz, Ana Ma
    Marco-Benedi, Victoria
    Lamiquiz-Moneo, Itziar
    FRONTIERS IN GENETICS, 2020, 11
  • [8] Imaging biomarkers to track subclinical atherosclerosis in heterozygous familial hypercholesterolemia
    Miname, Marcio H.
    Santos, Raul D.
    CLINICAL LIPIDOLOGY, 2013, 8 (02) : 231 - 242
  • [9] Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation
    Scicali, Roberto
    Di Pino, Antonino
    Pavanello, Chiara
    Ossoli, Alice
    Strazzella, Arianna
    Alberti, Antonia
    Di Mauro, Stefania
    Scamporrino, Alessandra
    Urbano, Francesca
    Filippello, Agnese
    Piro, Salvatore
    Rabuazzo, Agata Maria
    Calabresi, Laura
    Purrello, Francesco
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] Regulation of the LDL receptor in familial hypercholesterolemia
    Soutar, Anne K.
    CLINICAL LIPIDOLOGY, 2009, 4 (06) : 755 - 765